SCHEMBL9494861

SCHEMBL9494861

C=CCN1C(=O)C(C)(C)SC1=NN=C1SC(OP(=O)(O)OC)C(=O)N1C

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9492049 0.83 ALDH1A1 (0.39) ALDH1A1
SCHEMBL9493024 0.82 LMNA (0.40) ALDH1A1
SCHEMBL9618232 0.74 — —
SCHEMBL11097940 0.73 ALDH1A1 (0.41) ALDH1A1
SCHEMBL10881231 0.71 LMNA (0.39) ALDH1A1
SCHEMBL9493987 0.71 — —
SCHEMBL29378248 0.71 — —
SCHEMBL9492279 0.71 — —
Ammonia Solution, Strong SCHEMBL11203336 0.71 — —
SCHEMBL9492962 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0494047-A1 Use of carbazones for the treatment of rheumatoid diseases CIBA-GEIGY AG (CH) 1992-07-08 — — EP claimed
US-5177091-A Rheumatic disorders CIBA-GEIGY CORPORATION (US) 1993-01-05 — — US disclosed
EP-0494047-A1 Use of carbazones for the treatment of rheumatoid diseases CIBA-GEIGY AG (CH) 1992-07-08 — — EP disclosed
Send feedback